Viking Therapeutics (VKTX) Stock Price, Quote, News & History | Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD84,805.34+0.07%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

Viking Therapeutics Inc (VKTX) Stock Price, Quote, News & History

VKTXNASDAQ

Trade with Public

Trade with Public

$29.94

-0.57-1.87%

Last update: Oct 2, 7:58 PM

$30.03

-0.48-1.58%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$30.85

Close

$29.94

Volume / Avg.

6.37M / 3.81M

Day Range

$29.90 - $31.09

52 Wk Range

25.77 - 43.15

Market Cap

$3.77B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

18.91%

Days to Cover

12.32

Recent Viking Therapeutics, Inc. News

Benzinga Bulls and Bears: Costco, KB Home, McDonald’s

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

Benzinga Senior Editor

S&P 500 Erases Losses as US, Iran Reportedly Discuss Hormuz Deal: Stock Market Today

Stocks pared a sharp morning selloff after sources said US and Iranian negotiators are discussing a phased deal to reopen the Strait of Hormuz.

Piero Cingari

Crude Oil Rises Over 4%; Darden Earnings Miss Views

U.S. stocks fell Thursday: Dow -0.7%, S&P 500 -0.46%, Nasdaq -0.7%. Oil jumped 4.4%; Darden missed estimates, while APUS surged 163%.

Avi Kapoor

Why Is Viking Therapeutics Stock Trading Down Thursday?

A Viking Therapeutics announcement about an equity and debt offering fuels a reaction in the market.

Vandana Singh

Stitch Fix Posts Mixed Q4 Results, Joins Viking Therapeutics And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

U.S. futures fell as Stitch Fix plunged 18% on weak FY27 guidance; MGM, Viking Therapeutics and other stocks also declined premarket.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-418.44M

Investing Cash Flow (TTM)

399.26M

Financing Cash Flow (TTM)

111.25M

Free Cash Flow (TTM)

-418.44M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

92.06M

Analyst Trends and Forecast

1

Apr

2

May

1

Jul

1

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.27B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

9.39

Earnings Yield % (TTM)

-15.31%

Earnings Yield % (FWD)

-18.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.25

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$125.75M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-